Peer Review History
| Original SubmissionMay 24, 2021 |
|---|
|
PONE-D-21-17095 The Relationship of Tidal Volume and Driving Pressure with Mortality in Hypoxic Patients Receiving Mechanical Ventilation. PLOS ONE Dear Dr. Raschke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Corstiaan den Uil Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This study was funded in part by grant 2196 from the Flinn Foundation. SP was funded by NIH (HL126140, HL151254, AG059202, AI135108, HL140144, HL128954) and PCORI (DI- 2018C2-13161, EADI-16493, CER-2018C2-13262) at the time of writing this manuscript." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "No. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In a retrospective review of over 5000 patients and involving 18 intensive care units, the authors establish the relationship between two mechanical ventilation parameters: driving pressure (DP) and tidal volume/predicted body weight (TV/PBW) and mortality. The study concluded that: (1) driving pressure is significantly associated with mortality, consistent with the findings of Amato et al, and therefore needs to be considered when titrating ventilator settings and (2) that low-tidal volume ventilation (LTVV) may not be the optimal mechanical ventilation strategy for all patients but rather that intermediate-tidal volume ventilation (ITVV) may lead to superior patient outcomes. I applaud the authors on their study and in challenging the concept of LTVV, which has long-deserved additional reflection given the inability to replicate the results of the initial ARMA study, and in the absence of longitudinal change in ARDS-related mortality. Major Comments: The authors demonstrate that both DP and VT/PBW significantly modify mortality risk, however they did not provide data comparing DP to the (five) VT/PBW strata. This is important because if the (average) driving pressures were similar (but with different VT/PBW), this suggests that the compliance of the patients was different. This might suggest that the differences in mortality may have been modified by underlying patient lung disease severity/compliance rather than the VT/PBW. Minor Comments: - These study results suggest that the ARMA trial did not establish that 6mL/kg was optimal but that 12mL/kg was sub-optimal. In support of the findings of this study, it would be worth including a mention of the article published by Deans et al (Crit Care Med 2005 – PMID: 15891350) in the discussion as that study retrospectively analyzed the ARMA data and demonstrated that the mortality rates between the group of patients receiving 6mL/kg and those who were excluded from the study and receiving then-conventional ventilation (ITVV) had similar mortality rates. [They also demonstrated that the impact of tidal volumes on mortality was related to lung compliance or - in essence, but not in name - driving pressure.] - Recommend avoiding the use of contractions - Although ITVV was defined as an abbreviation (on the "Abbreviations" page - 3), its first use in the text is in the discussion (page 17). Recommend defining it in the text prior to its use. Reviewer #2: In this retrospective cohort, Dr Raschke et al studied over five thousand patients mechanically ventilated with PF ratios below 300 mHg in 18 ICUs in the southwestern United States. They found that tidal volume had a U-shaped relationship with hospital mortality and that driving pressure was also associated with hospital mortality even after adjusting for disease severity. I have some concerns and suggestions as detailed below. 1) My major concern is that the increased mortality in low tidal volume (<6mL/Kg PBW) be due to residual confounding. For example, patients with higher PEEP values due to hypoxemia might end up receiving lower tidal volumes to limit plateau pressure to less than 30 cmH2O as per protective ventilation protocols. I suggest that the authors include PEEP in the multivariable adjustment. 2) Respiratory system compliance can be a marker of the underlying severity of lung disease, but also varies according to patient lung size. Normalizing compliance to PBW (in mL/cmH2O/Kg PBW) helps take into account patient size. I suggest that the authors use normalized compliance in their multivariable adjustment. 3) Sample size was computed to find differences between groups. What groups? Please explain. 4) Why did the authors use ANOVA to compare the different TV/PBW strata? I believe that adding the strata to the multivariable logistic regression (as dummy variables) would have been a more natural choice. 5) Please explain in further detail how the driving pressure threshold of 19 cmH2O was found. 6) Please add the unit for the PF ratio (mmHg) 7) Is tidal volume still significantly associated with survival when driving pressure is in the model? This information is relevant because – if not – it would be simpler to target protection in terms of driving pressure. 8) Please discuss why the findings are in disagreement with those of Needham et al (BMJ 2012). In that prospective cohort study, they found that tidal volume had a linear relationship with survival. Modeling tidal volume with cubic splines did not improve the relationship. 9) How is it possible to reconcile the authors’ finding to those from Prevent trial (Simonis JAMA 2018) in which they tested a strategy with low vs intermediate tidal volumes in patients without ARDS? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Michaela Kollisch Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The Relationship of Tidal Volume and Driving Pressure with Mortality in Hypoxic Patients Receiving Mechanical Ventilation. PONE-D-21-17095R1 Dear Dr. Raschke, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Corstiaan den Uil Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-17095R1 The Relationship of Tidal Volume and Driving Pressure with Mortality in Hypoxic Patients Receiving Mechanical Ventilation. Dear Dr. Raschke: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Corstiaan den Uil Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .